# Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen

> **NCT00286871** · PHASE1 · COMPLETED · sponsor: **Duke University** · enrollment: 40 (—)

## Conditions studied

- Chronic Hepatitis C
- Organ Transplantation
- Immunosuppression

## Interventions

- **DRUG:** Neoral
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT00286871
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** —
- **Final completion:** 2009-02
- **Target enrollment:** 40 (—)
- **Last updated:** 2014-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00286871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00286871, "Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00286871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*